CD Biosynsis provides high-efficiency Corynebacterium glutamicum Gene Knockout Services, essential for the rational metabolic engineering of this critical industrial host. Gene knockout, the precise inactivation of target genes, is fundamental for redirecting carbon flux, preventing byproduct formation, and enhancing the yield of target compounds, such as amino acids and fine chemicals. Our platform utilizes advanced techniques, including optimized CRISPR-Cas9 systems and highly efficient marker-free homologous recombination protocols, tailored specifically for C. glutamicum. We ensure stable, precise, and permanent inactivation of target genes, delivering clean, high-performance knockout strains that are ready for immediate use in biomanufacturing scale-up and advanced strain development pipelines.
Get a QuoteGene knockout in C. glutamicum is often the first and most critical step in optimizing an industrial strain. By eliminating specific enzyme activities or regulatory functions, engineers can drastically improve pathway efficiency. Challenges associated with C. glutamicum include its robust cell wall structure and tendency for low homologous recombination efficiency with traditional methods. Our services overcome these hurdles by using CRISPR-assisted editing, resulting in near-perfect knockout success rates. We deliver strains with stable, marker-free chromosomal deletions, providing a streamlined chassis for subsequent complex pathway integrations and commercial production.
CRISPR-Cas9-mediated Knockout
Utilizing targeted Cas9 cleavage to induce double-strand breaks (DSBs), dramatically increasing the efficiency of homologous recombination for gene removal.
Large Fragment Deletion
Precise removal of large genomic regions, operons, or non-essential gene clusters to streamline the host genome for enhanced stability and resource allocation.
Essential Gene Knockout
Conditional gene inactivation (e.g., using tunable promoters or CRISPRi) for genes that are essential for viability under certain conditions.
Simultaneous Knockout
Implementation of multiplex CRISPR systems to inactivate multiple unlinked genes (e.g., 3-5 targets) in a single step for rapid strain creation.
Sequential Knockout Strategy
Stepwise deletion using recyclable selection markers or marker-free protocols for the construction of highly complex, multi-knockout strains.
Combinatorial Deletion Libraries
Creation of systematic libraries containing various combinations of gene knockouts for high-throughput screening and phenotypic optimization.
Marker-Free Deletion
Protocols designed to remove all antibiotic resistance genes or selection markers from the final strain, resulting in a cleaner, industry-ready chassis.
Minimal Scar Deletion
Precise removal of the target gene coding sequence, leaving only a minimal, non-coding 'scar' sequence (e.g., 30-50 bp) for maximum genomic fidelity.
Our meticulous process guarantees the precise deletion and rigorous verification of every modified locus.
1. Rational Design & Target Selection
2. CRISPR Vector & Donor Construction
3. Transformation & Clone Selection
4. Genetic Validation (QC)
Consultation to select the most impactful target genes based on metabolic flux analysis (if available).
Bioinformatic design of sgRNAs and homology arms for maximum efficiency and specificity.
Planning for marker-free removal or multiplex strategy.
Construction of the Cas9/sgRNA plasmid and the linear or plasmid-based repair template.
Optimization of template size and design for efficient C. glutamicum homologous recombination.
Efficient delivery of editing components via electroporation or conjugation.
Selection of initial positive transformants and subsequent curing of temporary plasmids/markers.
Isolation and expansion of individual knockout clones.
Metabolic Flux Redirection
Inactivation of enzymes in competing metabolic pathways to increase the flow of precursors toward the desired end-product (e.g., L-lysine).
Removal of Feedback Inhibition
Knockout of regulatory genes or transporters that mediate product-specific feedback inhibition or export limitations.
Enhanced Protein Secretion
Deletion of protease genes to minimize degradation of secreted recombinant proteins (enzymes, peptides) and improve final yield/purity.
Chassis Simplification
Removal of non-essential genes or mobile genetic elements to improve strain stability and reduce metabolic burden.
"The CRISPR-assisted knockout of a key competing pathway enzyme in our C. glutamicum strain was incredibly efficient. The resulting strain immediately showed a significant titer boost."
Dr. Chen, Head of Strain Engineering, Industrial Amino Acid Producer
"We required a $\Delta4$ strain with sequential, marker-free deletions. CD Biosynsis delivered the final chassis with perfect sequence fidelity at every locus, accelerating our entire timeline."
Mr. David Smith, Project Manager, Metabolic Pathway Optimization Group
"Their expertise in C. glutamicum allowed them to guide us to the optimal knockout targets. The resulting strain proved highly stable and reliable in our initial pilot fermentation runs."
Dr. Lena Koo, R&D Scientist, Synthetic Biology Startup
"The final documentation, including the CoA and sequencing traces, was comprehensive and met all of our quality assurance standards for regulatory review."
Dr. Alan Rivas, Lab Director, Applied Microbiology Institute
How does CRISPR-Cas9 improve gene knockout efficiency in C. glutamicum?
The CRISPR-Cas9 system creates a precise double-strand break (DSB) at the target locus, which significantly stimulates the cell's native DNA repair pathways, resulting in much higher homologous recombination and knockout rates than traditional plasmid-based methods.
Can you perform knockout of essential genes?
For essential genes, we offer conditional strategies (e.g., replacement with a tunable promoter or use of CRISPRi) that allow for controlled knockdown or inactivation under specific non-growth-limiting conditions.
What is the benefit of a marker-free knockout strain?
Marker-free strains are ideal for industrial use and regulatory compliance as they are free of antibiotic resistance genes. Furthermore, the absence of markers allows for sequential editing using the same selection marker multiple times.
How do you verify the sequence of the deletion?
Verification is rigorous: we use PCR to confirm the correct size change (deletion) and then use Sanger Sequencing across the entire deleted region junction to ensure the edit is 100% accurate and clean.
Do you offer multi-gene knockout services?
Yes. We specialize in both simultaneous (multiplex) and sequential multi-gene knockout construction to build complex, highly optimized production chassis efficiently.
What kind of deliverable documentation is provided?
The final deliverables include the frozen or lyophilized knockout strain, a detailed Certificate of Analysis (CoA), and all raw sequencing and QC data verifying the modification.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.